1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, September 2016

Biological Therapy Analysis & Statistics, September 2016

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

1-30 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6 995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

  • Industries : Pathology, Chronic Disease, Biotechnology, Biological Therapy
  • Countries : World
Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...

  • Industries : Therapy, Cancer, Oncology, Pathology, Biotechnology, Biological Therapy
  • Countries : World, United States, North America
Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

Stem Cell Banking Market by Bank Type, Service, Application, Region - Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute ...

  • Industries : Biological Therapy, Biotechnology, Banking, Financial Services
  • Countries : World, North America
Regenerative Medicines Market by Therapy, Product, Application, Region - Global Forecast to 2021

Regenerative Medicines Market by Therapy, Product, Application, Region - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global regenerative medicines market is expected to reach USD 49.41 billion by 2021 from USD 17.06 billion in 2016, at a CAGR of 23.7% during the period of 2016-2021. The global regenerative medicines ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World, Europe, North America
3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

  • Industries : Biological Therapy, In Vitro Diagnostics, Biotechnology, Medical Device
  • Countries : World, North America, Europe
Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

  • $ 5 000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

REPORT DESCRIPTION This report analyzes the current and future prospects of the regenerative medicine across the globe. Regenerative medicine is considered as an emerging field of medical science that ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World
Trends in Gene Therapy

Trends in Gene Therapy

  • $ 5 000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : Europe, United States
Genome Editing Global Market - Forecast to 2022

Genome Editing Global Market - Forecast to 2022

  • $ 4 950
  • Industry report
  • September 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Ever since the establishment of the genetic basis of life, researchers have tried to manipulate genes in plants and animals to improve traits. There has been a continuous evolution of gene modification ...

  • Industries : Biotechnology
  • Countries : World
3D Cell Culture Market Analysis By Technology, By Application,, By End Use And Segment Forecasts To 2024

3D Cell Culture Market Analysis By Technology, By Application,, By End Use And Segment Forecasts To 2024

  • $ 4 950
  • Industry report
  • August 2016
  • by Grand View Research

The global 3D cell culture market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Regenerative Medicine - The Future of Therapy (TechVision)

Regenerative Medicine - The Future of Therapy (TechVision)

  • $ 4 950
  • Industry report
  • July 2016
  • by Frost & Sullivan

Re-shaping Global Healthcare After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue ...

  • Industries : Biological Therapy
  • Countries : World
Global Laboratory  Reagents Industry

Global Laboratory  Reagents Industry

  • $ 4 950
  • Industry report
  • July 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Laboratory Chemical Reagents in US$ Thousand by the following Segments by Application Area: Molecular Biology (Monoclonal & Polyclonal Antibodies, Gene Expression, ...

  • Industries : Biotechnology, Genomics, Biological Therapy, In Vitro Diagnostics
  • Countries : World, Japan, United States, Europe, Canada
Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

  • $ 4 900
  • Industry report
  • August 2016
  • by Persistence Market Research

3D cell culture is a man-made environment which is created to allow cells to grow and interact with the surroundings in all three dimensions. It is an advanced cell culture technique that overcomes limitations ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • $ 4 740
  • Industry report
  • August 2016
  • by Allied Market Research

Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring ...

  • Industries : Biological Therapy
  • Countries : World
Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022

Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022

  • $ 4 550
  • Industry report
  • August 2016
  • by Hoovers Research

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present ...

  • Industries : Biological Therapy
  • Countries : World, Asia, North America, Europe
Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025

Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025

  • $ 4 200
  • Industry report
  • September 2016
  • by Accuray Research LLP

Global RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025 The Global RNAi Technologies Market is poised to grow at a CAGR of around 20.4% over the next decade to reach approximately ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
2016 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

2016 Cell Surface Markers: Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape--US, Europe (France, Germany, Italy, Spain, UK), Japan

  • $ 3 500
  • Industry report
  • September 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
Global Cell Surface Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

Global Cell Surface Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 3 500
  • Industry report
  • August 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC ...

  • Industries : Therapy, Biopharmaceutical, Biotechnology, Pharmaceutical, Biological Therapy
  • Countries : United States
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N Sulphoglucosamine Sulphohydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, United States
Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016’, ...

  • Industries : Biological Therapy, Pharmaceutical, Therapy, Drug Discovery and Development
  • Countries : United States, World
Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Papillomavirus Protein E6 (E6) - Pipeline Review, H2 2016’, provides in depth analysis on Human ...

  • Industries : Biopharmaceutical, Biological Therapy, Biotechnology, Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : United States
Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2016

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World
Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016’, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Biological Therapy, Chronic Disease, Biotechnology
  • Countries : United States
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Granulocyte ...

  • Industries : Biological Therapy, Therapy, Pathology, Biotechnology, Cancer, Pharmaceutical
  • Countries : United States
Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Macrophage Colony Stimulating Factor 1 Receptor (CSF 1 Receptor or Proto Oncogene c Fms or CD115 or CSF1R or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Macrophage Colony ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, World
Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical, Cancer, Pathology
  • Countries : United States
65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016

65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : United States, World
Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016

Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘ Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Pipeline Review, H1 2016’, ...

  • Industries : Biological Therapy, Therapy
  • Countries : United States, World, France

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.